Bridgeway Capital Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,000
Closed -$21.3K 1273
2025
Q4
$21.3K Sell
4,000
-7,500
-65% -$54.9K ﹤0.01% 1212
2025
Q3
$101K Hold
11,500
﹤0.01% 1111
2025
Q2
$80.2K Hold
11,500
﹤0.01% 1099
2025
Q1
$125K Sell
11,500
-10,000
-47% -$108K ﹤0.01% 1001
2024
Q4
$215K Buy
21,500
+2,220
+12% +$28K ﹤0.01% 987
2024
Q3
$318K Buy
19,280
+9,000
+88% +$128K 0.01% 966
2024
Q2
$114K Hold
10,280
﹤0.01% 1151
2024
Q1
$136K Sell
10,280
-1,000
-9% -$13K ﹤0.01% 1173
2023
Q4
$169K Sell
11,280
-3,500
-24% -$42.9K ﹤0.01% 1169
2023
Q3
$217K Buy
14,780
+5,000
+51% +$96.1K 0.01% 1084
2023
Q2
$245K Sell
9,780
-5,300
-35% -$88.8K 0.01% 1088
2023
Q1
$225K Buy
15,080
+5,000
+50% +$92.8K 0.01% 1084
2022
Q4
$141K Buy
10,080
+1,000
+11% +$27.3K ﹤0.01% 1162
2022
Q3
$287K Buy
9,080
+5,300
+140% +$222K 0.01% 1056
2022
Q2
$131K Sell
3,780
-6,000
-61% -$384K ﹤0.01% 1176
2022
Q1
$1.1M Hold
9,780
0.02% 757
2021
Q4
$936K Sell
9,780
-2,300
-19% -$207K 0.02% 802
2021
Q3
$1.07M Buy
+12,080
New +$1.19M 0.02% 800
2018
Q3
Sell
-467
Closed -$1.28M 1447
2018
Q2
$1.28M Buy
467
+125
+37% +$289K 0.01% 778
2018
Q1
$929K Buy
342
+120
+54% +$275K 0.01% 878
2017
Q4
$528K Sell
222
-216
-49% -$478K 0.01% 1078
2017
Q3
$884K Buy
438
+88
+25% +$115K 0.01% 885
2017
Q2
$406K Buy
350
+125
+56% +$167K ﹤0.01% 1144
2017
Q1
$360K Hold
225
﹤0.01% 1159
2016
Q4
$392K Hold
225
0.01% 1165
2016
Q3
$551K Buy
+225
New +$555K 0.01% 1050

Other funds holding IMUX